ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,867.60
      -0.80%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.265
      0.05%
      Bitcoin
      64,098.83
      -0.28%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE
      6. KV Pharmaceutical Co. CL A (KV.A)

      7. KV Pharmaceutical Co. CL A (KV.A) News

      KV.A

      K V Pharma (KV.A)

      KV Pharmaceutical Co. CL A
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NYSE:KV.A
      DateTimeSourceHeadlineSymbolCompany
      09/16/201310:26AMPR Newswire (US)KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million RecapitalizationNYSE:KV.AKV Pharmaceutical Co. CL A
      01/24/20138:00AMPR Newswire (US)Ther-Rx Corporation and Perrigo Company Announce the Availability of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%...NYSE:KV.AKV Pharmaceutical Co. CL A
      12/28/201212:43PMPR Newswire (US)K-V Pharmaceutical Receives Court Approval of Hologic SettlementNYSE:KV.AKV Pharmaceutical Co. CL A
      12/12/20126:39PMPR Newswire (US)K-V Pharmaceutical Secures Commitment for $85 Million Loan, Reaches Agreement with Senior Noteholders on Principal Terms of P...NYSE:KV.AKV Pharmaceutical Co. CL A
      08/10/20128:00AMPR Newswire (US)K-V Pharmaceutical Use of Cash Collateral Approved by U. S. Bankruptcy CourtNYSE:KV.AKV Pharmaceutical Co. CL A
      08/08/201211:09AMPR Newswire (US)K-V Pharmaceutical "First Day" Motions Approved by U.S. Bankruptcy CourtNYSE:KV.AKV Pharmaceutical Co. CL A
      08/07/201212:16PMPR Newswire (US)K-V Pharmaceutical Class A and Class B Common Stock Begin Trading on the OTC MarketsNYSE:KV.AKV Pharmaceutical Co. CL A
      08/06/20127:57AMPR Newswire (US)K-V Pharmaceutical Announces Planned Transition of Trading of Class A and Class B Common Shares to the OTC MarketsNYSE:KV.AKV Pharmaceutical Co. CL A
      08/04/201212:56AMPR Newswire (US)K-V Pharmaceutical Company Files Voluntary Petitions for Reorganization to Restructure Financial ObligationsNYSE:KV.AKV Pharmaceutical Co. CL A
      08/03/201211:27AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NYSE:KV.AKV Pharmaceutical Co. CL A
      07/31/20125:09PMEdgar (US Regulatory)Securities Registration Statement (S-1)NYSE:KV.AKV Pharmaceutical Co. CL A
      07/26/20124:27PMEdgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NYSE:KV.AKV Pharmaceutical Co. CL A
      07/20/20124:05PMPR Newswire (US)K-V Pharmaceutical Company Announces Additional Notification from NYSE Regarding Listing CriteriaNYSE:KV.AKV Pharmaceutical Co. CL A
      07/13/20124:43PMEdgar (US Regulatory)Amended Current report filing (8-K/A)NYSE:KV.AKV Pharmaceutical Co. CL A
      07/06/20124:21PMEdgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
      07/03/20123:35PMEdgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
      07/02/20129:15AMPR Newswire (US)FDA Issues Further Guidance About Makena®NYSE:KV.AKV Pharmaceutical Co. CL A
      06/29/20126:51PMPR Newswire (US)K-V Pharmaceutical Company Announces Notification from NYSE Regarding Listing CriteriaNYSE:KV.AKV Pharmaceutical Co. CL A
      06/22/20124:32PMEdgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
      06/20/20124:19PMEdgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
      06/18/20124:36PMEdgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NYSE:KV.AKV Pharmaceutical Co. CL A
      06/18/20129:14AMPR Newswire (US)FDA and CMS Issue Important Updates on Makena®NYSE:KV.AKV Pharmaceutical Co. CL A
      06/07/20125:12PMEdgar (US Regulatory)Current report filing (8-K)NYSE:KV.AKV Pharmaceutical Co. CL A
      05/25/20124:15PMPR Newswire (US)K-V Pharmaceutical Company States That Its Policy is Not to Comment on Unusual Market ActivityNYSE:KV.AKV Pharmaceutical Co. CL A
      05/16/20125:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
      05/16/20125:42PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
      05/16/20123:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
      05/16/20123:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
      05/16/20123:41PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
      05/16/20123:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:KV.AKV Pharmaceutical Co. CL A
       Showing the most relevant articles for your search:NYSE:KV.A